Pentagon Posts (Then Deletes) Plans For Hegseth’s “High-T” Testosterone Military

The Defense Department published detailed clinical guidance for Pete Hegseth’s orders to screen military service members for testosterone deficiencies on Wednesday.

By Thursday, the instructions had disappeared from the Pentagon website.

A statement from a Pentagon official said, “The draft (document) published on September 2, 2026, has been temporarily rescinded to allow for updates,” adding that interim guidance remains in effect.

The Pentagon is temporarily rescinding recently published clinical guidance for a new mandatory testosterone-deficiency screening policy, Reuters reports. https://t.co/siyHUrXg2S

— Military Times (@MilitaryTimes) September 3, 2026

Back in July, Hegseth announced his plans for “The High-T Department of War” which would include testing active and reserve troops age 30 and older. Hegseth apparently sees hormone therapy as a means to physical strength and combat readiness.

Ironically, Hegseth wants to deny that same testosterone therapy to active trans troops.

Women wouldn’t receive testosterone blood tests but would be screened annually for fatigue, menstrual disruption and other possible signs of hormonal dysregulation.

The newly-posted guidance was to take effect immediately and remain in force for at least one year. But the Pentagon instead removed it before most service members even knew it existed.

More from The Advocate:

Hegseth’s program has also made the Trump administration’s selective reasoning about hormone care increasingly difficult to disguise.

The Pentagon promotes testosterone treatment for service members it presumes to be cisgender as an investment in readiness. At the same time, it is removing transgender troops from the military and restricting their access to gender-affirming hormone care, which the administration has characterized as costly, burdensome and incompatible with service.

That contradiction has reached federal court. The Trump administration has argued that transgender troops may be excluded partly because they require continuing medical treatment.

In July, U.S. District Judge Ana Reyes ordered government lawyers to explain how that claim could coexist with Hegseth’s plan to establish routine hormone screening and treatment for other troops.

Last week, the Trump administration asked the U.S. Supreme Court to intervene in that case.

“Page Not Found” appeared on websites for both the Pentagon and Defense Health Agency when clicking on links for the memo and statement.

Pentagon Rescinds Mandatory Testosterone Screening Guidance—For Nowhttps://t.co/eail24OGZi pic.twitter.com/AF3mQisMPp

— Forbes (@Forbes) September 3, 2026